SI
SI
discoversearch

Biotech / Medical
Dynavax DVAX
An SI Board Since August 2004
Posts SubjectMarks Bans Symbol
144 21 0 DVAX
Emcee:  keokalani'nui Type:  Moderated
IPO 2/20/04 at $7.50

Clinical Programs:

--Ragweed/Seasonal Allergy
--Asthma
--Hep B

8/04 price: $5.00
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
144DVAX launches. Bewildered that the PRODUCT could be brought out of mothball to scaram(o)uche-January 8
1438-K out, contract with this outfit for vaccine detailing...... inventivhealth.cscaram(o)uche-11/14/2017
142ATM was increased by $25m a few days ago. My basis went from about $4 to $17.40scaram(o)uche-11/14/2017
141AZD1419 trial recently updated....... dynavax.com And I don't know if anyoscaram(o)uche-11/14/2017
140pbs.twimg.comscaram(o)uche111/9/2017
139Dino, if you're out there........ congratulations! Adjuvants...... scaram(o)uche-11/9/2017
138We have reinitiated preparations for the launch of HEPLISAV-B, including resumptscaram(o)uche-11/3/2017
137On watch for clear above 19.60. [graphic]hollyhunter-9/6/2017
136"Dynavax anticipates using the net proceeds from the proposed offering to fscaram(o)uche-8/9/2017
135Oh wow. Priced at 15. Wow, wow, wow. Gray should get tarred (cold, harmless) scaram(o)uche-8/9/2017
134Down 5%, which fits this sort of dilution. Deeper than I had hoped for. So, whscaram(o)uche-8/9/2017
133oooooops! ;-) Message 31215377 Only 4 hours ago, but I have no clue what I wascaram(o)uche-8/8/2017
132But...... Every time I lean on the F word, I end up remembering what FDA was liscaram(o)uche-7/31/2017
131 [graphic] [graphic] [graphic]The Ox-7/31/2017
130Right?? crazy to ride this one. mopgcw-7/31/2017
129Been watching FDA closely for over three decades. Big believer, imo best regulascaram(o)uche17/28/2017
128pbs.twimg.comscaram(o)uche17/28/2017
127So... up 4%, regular hours, another 20% after hours. More action, Monday morscaram(o)uche-6/3/2017
126>> loses an in-house competitor << Well, no. Competitor will livescaram(o)uche-5/10/2017
125AstraZeneca’s PhIII bid on asthma drug tralokinumab flops endpts.com AZD1419 lscaram(o)uche-5/10/2017
124Re. AZD1419 (and DV281?), phase II trial for latter is being routinely updated ascaram(o)uche-4/13/2017
123 Dynavax Presents Promising Clinical Data from Lead Immuno-Oncology Candidate, SSavant-3/9/2017
122fwiw, i am still holding a bit. i took some chips off the table when it was armopgcw-3/7/2017
121>> Thou shalt go to hell and back, and then add 10 years. << Make tscaram(o)uche-3/7/2017
120DVAX charts [graphic] [graphic] The Ox-5/4/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.